Synonyms: AT-1001 | AT-2347 | AT1001 | AT2347
Compound class:
Peptide
Comment: Larazotide (AT1001) is an eight amino acid oligopeptide. Its sequence is derived from the zonula occludens toxin that is secreted by Vibrio cholerae. In human tissues larazotide acts to restore the intercellular tight junction complex [1-2] and regulates epithelial and endothelial permeability by antagonising the effects of zonulin on the tight junction protein 1 (TJP1). Larazotide was proposed for potential therapeutic application in celiac disease where tight junctions and intestinal permeability are dysregulated [3-5].
|
|
Classification ![]() |
|
Compound class | Peptide |
International Nonproprietary Names ![]() |
|
INN number | INN |
8951 | larazotide |
Synonyms ![]() |
AT-1001 | AT-2347 | AT1001 | AT2347 |
Database Links ![]() |
|
CAS Registry No. | 258818-34-7 (source: WHO INN record) |
ChEBI | CHEBI:177799 |
ChEMBL Ligand | CHEMBL2105646 |
DrugBank Ligand | DB05645 |
GtoPdb PubChem SID | 507750358 |
PubChem CID | 9810532 |
Search Google for chemical match using the InChIKey | ORFLZNAGUTZRLQ-ZMBVWFSWSA-N |
Search Google for chemicals with the same backbone | ORFLZNAGUTZRLQ |
Search PubMed clinical trials | larazotide |
Search PubMed titles | larazotide |
Search PubMed titles/abstracts | larazotide |
UniChem Compound Search for chemical match using the InChIKey | ORFLZNAGUTZRLQ-ZMBVWFSWSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ORFLZNAGUTZRLQ-ZMBVWFSWSA-N |